summary
Introduced
01/10/2025
01/10/2025
In Committee
03/21/2025
03/21/2025
Crossed Over
Passed
Dead
Introduced Session
Potential new amendment
104th General Assembly
Bill Summary
Creates the Wholesale Prescription Drug Importation Program Act. Requires the Department of Public Health to establish the Wholesale Prescription Drug Importation Program. Provides that the Department shall implement the program by: contracting with one or more prescription drug wholesalers and Canadian suppliers to import prescription drugs and provide prescription drug cost savings to consumers in this State; developing a registration process for health benefit plan issuers, health care providers, and pharmacies to obtain and dispense prescription drugs imported under the program; developing a list of prescription drugs, including the prices of those drugs, that meet certain requirements set forth under the Act and publishing the list on the Department's website; establishing an outreach and marketing plan to generate program awareness; ensuring the program and the prescription drug wholesalers that contract with this State comply with certain federal tracking, tracing, verification, and identification requirements; and other actions. Sets forth eligibility criteria for prescription drugs that may be imported into the State under the program. Contains provisions concerning anticompetitive behavior monitoring; program funding; program expansion; audit procedures; annual reporting requirements; the adoption of rules to implement the Act; and federal waiver or authorization requirements. Effective July 1, 2025.
AI Summary
This bill establishes the Wholesale Prescription Drug Importation Program in Illinois, which aims to provide consumers with lower-cost prescription drugs imported from Canada. The Department of Public Health will create and manage the program by contracting with drug wholesalers and Canadian suppliers, developing a registration process for health benefit plans and pharmacies, and creating a list of eligible imported drugs. To qualify for importation, drugs must meet FDA safety standards, not violate patent laws, be expected to generate cost savings, and cannot be controlled substances, biological products, infused drugs, intravenous drugs, surgical inhalants, or parenteral drugs. The program includes provisions for monitoring anticompetitive behavior, establishing funding mechanisms, conducting audits, and requiring annual reports to the Governor and General Assembly. The Department may expand the program to import drugs from other countries allowed by federal law and will ensure compliance with federal tracking and verification requirements. The program is set to begin on July 1, 2025, and the Department will develop necessary rules for implementation, with the ability to delay implementation if federal waivers or authorizations are required.
Committee Categories
Budget and Finance
Sponsors (1)
Last Action
House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee (on 03/21/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=1272&GAID=18&DocTypeID=HB&SessionID=114&GA=104 |
| House Amendment 001 | https://www.ilga.gov/legislation/104/HB/10400HB1272ham001.htm |
| BillText | https://www.ilga.gov/legislation/104/HB/10400HB1272.htm |
Loading...